{"id":2663,"date":"2016-04-22T09:16:40","date_gmt":"2016-04-22T13:16:40","guid":{"rendered":"https:\/\/medicarereport.org\/?p=2663"},"modified":"2016-04-22T09:16:40","modified_gmt":"2016-04-22T13:16:40","slug":"more-exchange-plans-offer-patients-easier-access-to-some-expensive-drugs-report","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=2663","title":{"rendered":"More Exchange Plans Offer Patients Easier Access To Some Expensive Drugs: Report"},"content":{"rendered":"

(By Michelle Andrews for Kaiser Health News)<\/p>\n

Some people with cancer, HIV and multiple sclerosis have\u00a0better access to\u00a0high-cost specialty drugs in marketplace plans this year, yet a significant proportion of these plans still place many expensive drugs\u00a0in cost-sharing categories that require the highest patient out-of-pocket costs, according to a new analysis.<\/p>\n

The\u00a0<\/span>report\u00a0by Avalere Health<\/a>\u00a0examined how silver-level plans handled 20 classes of medications that are used to treat complex and expensive diseases such as HIV, cancer, hepatitis C and bipolar disorder. Read article here….<\/a><\/p>\n

Kaiser Health News\u00a0is\u00a0a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n

\"khn-logo1\"<\/a><\/p>\n

Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Michelle Andrews for Kaiser Health News) Some people with cancer, HIV and multiple sclerosis have\u00a0better access to\u00a0high-cost specialty drugs<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,15],"tags":[],"class_list":["post-2663","post","type-post","status-publish","format-standard","hentry","category-affordable-care-act-aca","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/2663","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2663"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/2663\/revisions"}],"predecessor-version":[{"id":2664,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/2663\/revisions\/2664"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2663"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2663"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}